IBDEI0NA ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11403,1,4,0)
 ;;=4^V17.3
 ;;^UTILITY(U,$J,358.3,11403,1,5,0)
 ;;=5^Family h/o Ischemic Heart Dis
 ;;^UTILITY(U,$J,358.3,11403,2)
 ;;=^295305
 ;;^UTILITY(U,$J,358.3,11404,0)
 ;;=V16.6^^64^697^17
 ;;^UTILITY(U,$J,358.3,11404,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11404,1,4,0)
 ;;=4^V16.6
 ;;^UTILITY(U,$J,358.3,11404,1,5,0)
 ;;=5^Family h/o Leukemia
 ;;^UTILITY(U,$J,358.3,11404,2)
 ;;=^295298
 ;;^UTILITY(U,$J,358.3,11405,0)
 ;;=V18.61^^64^697^19
 ;;^UTILITY(U,$J,358.3,11405,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11405,1,4,0)
 ;;=4^V18.61
 ;;^UTILITY(U,$J,358.3,11405,1,5,0)
 ;;=5^Family h/o Polycystic Kidney
 ;;^UTILITY(U,$J,358.3,11405,2)
 ;;=^321531
 ;;^UTILITY(U,$J,358.3,11406,0)
 ;;=V17.0^^64^697^20
 ;;^UTILITY(U,$J,358.3,11406,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11406,1,4,0)
 ;;=4^V17.0
 ;;^UTILITY(U,$J,358.3,11406,1,5,0)
 ;;=5^Family h/o Psychiatric Condition
 ;;^UTILITY(U,$J,358.3,11406,2)
 ;;=^295302
 ;;^UTILITY(U,$J,358.3,11407,0)
 ;;=V19.4^^64^697^21
 ;;^UTILITY(U,$J,358.3,11407,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11407,1,4,0)
 ;;=4^V19.4
 ;;^UTILITY(U,$J,358.3,11407,1,5,0)
 ;;=5^Family h/o Skin Condition
 ;;^UTILITY(U,$J,358.3,11407,2)
 ;;=^295324
 ;;^UTILITY(U,$J,358.3,11408,0)
 ;;=V17.1^^64^697^22
 ;;^UTILITY(U,$J,358.3,11408,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11408,1,4,0)
 ;;=4^V17.1
 ;;^UTILITY(U,$J,358.3,11408,1,5,0)
 ;;=5^Family h/o Stroke (CVA)
 ;;^UTILITY(U,$J,358.3,11408,2)
 ;;=^295303
 ;;^UTILITY(U,$J,358.3,11409,0)
 ;;=V16.8^^64^697^12
 ;;^UTILITY(U,$J,358.3,11409,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11409,1,4,0)
 ;;=4^V16.8
 ;;^UTILITY(U,$J,358.3,11409,1,5,0)
 ;;=5^Family h/o Cancer,Other Specified
 ;;^UTILITY(U,$J,358.3,11409,2)
 ;;=^295300
 ;;^UTILITY(U,$J,358.3,11410,0)
 ;;=V11.1^^64^697^24
 ;;^UTILITY(U,$J,358.3,11410,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11410,1,4,0)
 ;;=4^V11.1
 ;;^UTILITY(U,$J,358.3,11410,1,5,0)
 ;;=5^Hx of Affective Disorder
 ;;^UTILITY(U,$J,358.3,11410,2)
 ;;=^295250
 ;;^UTILITY(U,$J,358.3,11411,0)
 ;;=V15.89^^64^697^46
 ;;^UTILITY(U,$J,358.3,11411,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11411,1,4,0)
 ;;=4^V15.89
 ;;^UTILITY(U,$J,358.3,11411,1,5,0)
 ;;=5^Hx of Persian Gulf Region Exposure
 ;;^UTILITY(U,$J,358.3,11411,2)
 ;;=^295291
 ;;^UTILITY(U,$J,358.3,11412,0)
 ;;=V11.3^^64^697^25
 ;;^UTILITY(U,$J,358.3,11412,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11412,1,4,0)
 ;;=4^V11.3
 ;;^UTILITY(U,$J,358.3,11412,1,5,0)
 ;;=5^Hx of Alcoholism
 ;;^UTILITY(U,$J,358.3,11412,2)
 ;;=^295252
 ;;^UTILITY(U,$J,358.3,11413,0)
 ;;=V15.07^^64^697^26
 ;;^UTILITY(U,$J,358.3,11413,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11413,1,4,0)
 ;;=4^V15.07
 ;;^UTILITY(U,$J,358.3,11413,1,5,0)
 ;;=5^Hx of Allergy to Latex
 ;;^UTILITY(U,$J,358.3,11413,2)
 ;;=^322043
 ;;^UTILITY(U,$J,358.3,11414,0)
 ;;=V13.4^^64^697^27
 ;;^UTILITY(U,$J,358.3,11414,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11414,1,4,0)
 ;;=4^V13.4
 ;;^UTILITY(U,$J,358.3,11414,1,5,0)
 ;;=5^Hx of Arthritis
 ;;^UTILITY(U,$J,358.3,11414,2)
 ;;=^295267
 ;;^UTILITY(U,$J,358.3,11415,0)
 ;;=V12.72^^64^697^31
 ;;^UTILITY(U,$J,358.3,11415,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11415,1,4,0)
 ;;=4^V12.72
 ;;^UTILITY(U,$J,358.3,11415,1,5,0)
 ;;=5^Hx of Colon Polyps
 ;;^UTILITY(U,$J,358.3,11415,2)
 ;;=^303401
 ;;^UTILITY(U,$J,358.3,11416,0)
 ;;=V12.59^^64^697^30
 ;;^UTILITY(U,$J,358.3,11416,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11416,1,4,0)
 ;;=4^V12.59
 ;;^UTILITY(U,$J,358.3,11416,1,5,0)
 ;;=5^Hx of CHF
 ;;^UTILITY(U,$J,358.3,11416,2)
 ;;=^303399
